SIS
LEXX icon

Sound Income Strategies’s Lexaria Bioscience LEXX Stock Holding History

Sound Income Strategies’s Portfolio LEXX Stock Details LEXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1
Closed -$38 – 1663
2025
Q1 		$38 Hold
1
– – ﹤0.01% 1511
2024
Q4 		$47 Hold
1
– – ﹤0.01% 1431
2024
Q3 		$68 Buy
+1
New +$48 ﹤0.01% 1369
2024
Q1 		– Sell
-1
Closed -$28 – 1404
2023
Q4 		$28 Buy
+1
New +$19 ﹤0.01% 1300

Other funds holding LEXX

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BAM
Byrne Asset Management Kingston, New Jersey $185M AUM 41.05% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Sound Income Strategies's LEXX Position: Q2 2025 in Review

Sound Income Strategies sold out of Lexaria Bioscience (LEXX) in Q2 2025, closing a stake of 1 share — an estimated $38 sold.

Sound Income Strategies first reported a position in LEXX in Q4 2023 and held it in 4 quarters. The position peaked at $68 in Q3 2024. 21 funds tracked by Wall St. Rank hold LEXX as of Q2 2025.

  • Sound Income Strategies reported no remaining Lexaria Bioscience position as of Q2 2025 after selling out during the quarter.
  • Sound Income Strategies sold 1 Lexaria Bioscience share in Q2 2025, an estimated $38.
  • Sound Income Strategies first reported a position in Lexaria Bioscience in Q4 2023 and held it in 4 quarters.
  • Sound Income Strategies's Lexaria Bioscience position peaked at $68 in Q3 2024.
  • 21 funds tracked by Wall St. Rank held Lexaria Bioscience as of Q2 2025.

Based on Sound Income Strategies's 13F filing for Q2 2025, filed 17 Jul 2025.